Intra-arterial peptide receptor radionuclide therapy (IA-PRRT) in patients with SSTR-expressing neuroendocrine neoplasms: short- and long-term safety and efficacy for up to 13 years.

Saved in:

Bibliographic Details
Title:	Intra-arterial peptide receptor radionuclide therapy (IA-PRRT) in patients with SSTR-expressing neuroendocrine neoplasms: short- and long-term safety and efficacy for up to 13 years.
Authors:	Zhang J; Department of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 119074, Singapore.; Theranostics Center of Excellence, Yong Loo Lin School of Medicine, National University of Singapore, 11 Biopolis Way, Helios, Singapore 138667, Singapore.; Clinical Imaging Research Centre, Centre for Translational Medicine, National University of Singapore, Singapore 117599, Singapore.; Nanomedicine Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore., Mensel B; Department of Diagnostic & Interventional Radiology, Philipps-University Marburg, Germany.; Department of Diagnostic and Interventional Radiology and Neuroradiology, Central Hospital Bad Berka, Germany., Baum RP; Curanosticum Wiesbaden-Frankfurt, Department of Molecular Radiotherapy, ICPO Center of Excellence, DKD HELIOS Klinik, Wiesbaden, Germany.; THERANOSTICS Center for Molecular Radiotherapy and Molecular Imaging, ENETS Center of Excellence, Zentralklinik Bad Berka, Bad Berka, 99437, Germany.
Source:	Theranostics [Theranostics] 2026 Jan 01; Vol. 16 (4), pp. 1658-1670. Date of Electronic Publication: 2026 Jan 01 (Print Publication: 2026).
Publication Type:	Journal Article
Journal Info:	Publisher: Ivyspring International Publisher Country of Publication: Australia NLM ID: 101552395 Publication Model: eCollection Cited Medium: Internet ISSN: 1838-7640 (Electronic) Linking ISSN: 18387640 NLM ISO Abbreviation: Theranostics Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1838-7640
DOI:	10.7150/thno.112012